Avanos Medical, Inc. (NYSE:AVNS) Shares Acquired by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. lifted its holdings in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 14,386.9% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,829 shares of the company's stock after purchasing an additional 28,630 shares during the period. Harbor Capital Advisors Inc. owned 0.06% of Avanos Medical worth $413,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. T. Rowe Price Investment Management Inc. increased its position in shares of Avanos Medical by 27.2% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 3,011,312 shares of the company's stock valued at $47,941,000 after acquiring an additional 644,267 shares during the last quarter. Brown Advisory Inc. raised its position in Avanos Medical by 12.0% during the fourth quarter. Brown Advisory Inc. now owns 1,905,094 shares of the company's stock valued at $30,329,000 after purchasing an additional 204,218 shares in the last quarter. D. E. Shaw & Co. Inc. increased its holdings in shares of Avanos Medical by 43.1% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 494,627 shares of the company's stock worth $7,874,000 after buying an additional 148,902 shares during the period. JPMorgan Chase & Co. grew its stake in shares of Avanos Medical by 189.8% in the fourth quarter. JPMorgan Chase & Co. now owns 201,634 shares of the company's stock worth $3,210,000 after purchasing an additional 132,063 shares during the last quarter. Finally, Bridgeway Capital Management LLC grew its stake in shares of Avanos Medical by 87.6% in the fourth quarter. Bridgeway Capital Management LLC now owns 273,251 shares of the company's stock worth $4,350,000 after purchasing an additional 127,591 shares during the last quarter. Institutional investors own 95.17% of the company's stock.

Avanos Medical Price Performance

AVNS stock traded down $0.26 during trading on Friday, reaching $12.11. The company's stock had a trading volume of 282,530 shares, compared to its average volume of 371,973. Avanos Medical, Inc. has a 1 year low of $11.84 and a 1 year high of $25.36. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $560.01 million, a P/E ratio of 35.62 and a beta of 1.14. The company's fifty day moving average is $12.52 and its 200-day moving average is $14.79.

Avanos Medical (NYSE:AVNS - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.19 by $0.07. The firm had revenue of $167.50 million during the quarter, compared to analyst estimates of $161.75 million. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. The business's quarterly revenue was up .8% compared to the same quarter last year. During the same quarter last year, the business posted $0.22 earnings per share. On average, research analysts expect that Avanos Medical, Inc. will post 1.32 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised Avanos Medical from a "hold" rating to a "buy" rating in a research report on Wednesday, March 19th.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.